The anti-malaria drug hydroxychloroquine helped lower the death rate in Covid-19 patients in the most recent study of the drug conducted by Henry Ford Health System.
Cardiologist Dr. William O’Neill, a medical director at the Henry Ford Health System in Detroit, Michigan, first spoke with “Full Measure” about the study while it was underway in May. The findings have just been published in the peer-reviewed International Journal of Infectious Diseases.
The large scale analysis examined 2,541 patients who had been hospitalized in six hospitals between March 10 and May 2, 2020.
More than twenty-six percent (26.4%) of patients who did not receive hydroxychloroquine died. Nearly seventy-four percent (73.6%) survived.
But among those who received hydroxychloroquine: 13% died and 87% survived.
Sharyl Attkisson – sharylattkisson.com – July 2, 2020.
Want More Investigative Content?
